Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Metabolism Energy Metabolism

Anti-SUCLA2 antibody (ab133956)

Price and availability

244 579 ₸

Availability

Order now and get it on Thursday February 25, 2021

Anti-SUCLA2 antibody (ab133956)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to SUCLA2
  • Suitable for: IHC-P, WB
  • Reacts with: Mouse, Human
  • Isotype: IgG

You may also be interested in

Product image
Anti-GALM antibody (ab151485)
Product image
Anti-GAPDS antibody (ab247039)
Product image
Anti-PDHA1 antibody [EPR11098] - BSA and Azide free (ab176835)
Product image
Recombinant Human MGEA5/OGA protein (ab153117)

Overview

  • Product name

    Anti-SUCLA2 antibody
    See all SUCLA2 primary antibodies
  • Description

    Rabbit polyclonal to SUCLA2
  • Host species

    Rabbit
  • Tested applications

    Suitable for: IHC-P, WBmore details
  • Species reactivity

    Reacts with: Mouse, Human
    Predicted to work with: Rat, Chimpanzee, Macaque monkey, Gorilla, Orangutan
  • Immunogen

    Synthetic peptide corresponding to Human SUCLA2 aa 200-300 conjugated to keyhole limpet haemocyanin.
    Database link: Q9P2R7

  • Positive control

    • This antibody gave a positive signal in the following tissue lysates: Human Heart; Human Mitochondrial Heart ; Mouse Heart. This antibody gave a positive result in IHC in the following FFPE tissue: Human normal heartmuscle.
  • General notes

    Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.

    Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.

    We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.

    In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.

    We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.

    Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.

    Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 7.40
    Preservative: 0.02% Sodium azide
    Constituent: PBS

    Batches of this product that have a concentration
  • Concentration information loading...
  • Purity

    Immunogen affinity purified
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Signal Transduction
    • Metabolism
    • Energy Metabolism
    • Signal Transduction
    • Metabolism
    • Mitochondrial
    • Neuroscience
    • Sensory System
    • Auditory system
    • Cardiovascular
    • Heart
    • Cardiac metabolism
    • Metabolism
    • Pathways and Processes
    • Mitochondrial Metabolism
    • Mitochondrial markers
    • Metabolism
    • Pathways and Processes
    • Metabolic signaling pathways
    • Energy transfer pathways
    • Energy Metabolism

Associated products

  • Compatible Secondaries

    • Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077)
    • Goat Anti-Rabbit IgG H&L (HRP) (ab205718)
  • Isotype control

    • Rabbit IgG, polyclonal - Isotype Control (ChIP Grade) (ab171870)

Applications

Our Abpromise guarantee covers the use of ab133956 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P Use a concentration of 5 µg/ml. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
WB 1/250. Detects a band of approximately 45 kDa (predicted molecular weight: 50 kDa).

Target

  • Function

    Catalyzes the ATP-dependent ligation of succinate and CoA to form succinyl-CoA.
  • Tissue specificity

    Widely expressed. Not expressed in liver and lung.
  • Pathway

    Carbohydrate metabolism; tricarboxylic acid cycle; succinate from succinyl-CoA (ligase route): step 1/1.
  • Involvement in disease

    Mitochondrial DNA depletion syndrome 5
  • Sequence similarities

    Belongs to the succinate/malate CoA ligase beta subunit family.
    Contains 1 ATP-grasp domain.
  • Cellular localization

    Mitochondrion.
  • Target information above from: UniProt accession Q9P2R7 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links

    • Entrez Gene: 8803 Human
    • Entrez Gene: 20916 Mouse
    • Entrez Gene: 361071 Rat
    • Omim: 603921 Human
    • SwissProt: Q9P2R7 Human
    • SwissProt: Q9Z2I9 Mouse
    • Unigene: 743361 Human
    • Unigene: 38951 Mouse
    • Alternative names

      • A BETA antibody
      • A SCS antibody
      • ATP specific succinyl CoA synthetase subunit beta antibody
      • ATP specific succinyl CoA synthetase, beta subunit antibody
      • ATP-specific succinyl-CoA synthetase subunit beta antibody
      • Mitochondrial succinyl CoA ligase [ADP forming] subunit beta antibody
      • MTDPS5 antibody
      • Renal carcinoma antigen NY-REN-39 antibody
      • Renal carcinoma antigen NYREN39 antibody
      • SCS betaA antibody
      • SCS-betaA antibody
      • SUCB1_HUMAN antibody
      • Succinate CoA ligase (ADP forming) antibody
      • Succinate CoA ligase [ADP forming] subunit beta, mitochondrial; succinyl CoA ligase [ADP forming] subunit beta, mitochondrial antibody
      • Succinate CoA ligase ADP forming beta subunit antibody
      • Succinate CoA ligase beta subunit antibody
      • Succinyl CoA ligase [ADP-forming] subunit beta, mitochondrial antibody
      • Succinyl CoA synthetase beta A chain antibody
      • Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial antibody
      • Succinyl-CoA synthetase beta-A chain antibody
      • SUCLA2 antibody
      see all

    Images

    • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SUCLA2 antibody (ab133956)
      Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SUCLA2 antibody (ab133956)

      IHC image of SUCLA2 staining in Human normal heartmuscle formalin fixed paraffin embedded tissue section, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval (EDTA based pH 9.0 solution, epitope retrieval solution 2) for 20 mins. The section was then incubated with ab133956, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

       

      For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

    • Western blot - Anti-SUCLA2 antibody (ab133956)
      Western blot - Anti-SUCLA2 antibody (ab133956)
      All lanes : Anti-SUCLA2 antibody (ab133956) at 1/250 dilution

      Lane 1 : Heart (Human) Tissue Lysate - adult normal tissue
      Lane 2 : Human Heart Mitochondrial Lysate
      Lane 3 : Heart (Mouse) Tissue Lysate

      Lysates/proteins at 10 µg per lane.

      Secondary
      All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/10000 dilution

      Developed using the ECL technique.

      Performed under reducing conditions.

      Predicted band size: 50 kDa
      Observed band size: 45 kDa
      why is the actual band size different from the predicted?
      Additional bands at: 17 kDa (possible non-specific binding), 58 kDa (possible non-specific binding), 90 kDa (possible non-specific binding)


      Exposure time: 4 minutes


      The band observed at 45 kDa could potentially be a cleaved form of SUCLA2 due to the presence of 52 amino acid Transit peptide.

      This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 5% Bovine Serum Albumin before being incubated with ab133956 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution.

    Protocols

    • Western blot protocols
    • Immunohistochemistry protocols

    Click here to view the general protocols

    Datasheets and documents

    • Datasheet
  • References (0)

    Publishing research using ab133956? Please let us know so that we can cite the reference in this datasheet.

    ab133956 has not yet been referenced specifically in any publications.

    Images

    • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SUCLA2 antibody (ab133956)
      Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SUCLA2 antibody (ab133956)

      IHC image of SUCLA2 staining in Human normal heartmuscle formalin fixed paraffin embedded tissue section, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval (EDTA based pH 9.0 solution, epitope retrieval solution 2) for 20 mins. The section was then incubated with ab133956, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

       

      For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

    • Western blot - Anti-SUCLA2 antibody (ab133956)
      Western blot - Anti-SUCLA2 antibody (ab133956)
      All lanes : Anti-SUCLA2 antibody (ab133956) at 1/250 dilution

      Lane 1 : Heart (Human) Tissue Lysate - adult normal tissue
      Lane 2 : Human Heart Mitochondrial Lysate
      Lane 3 : Heart (Mouse) Tissue Lysate

      Lysates/proteins at 10 µg per lane.

      Secondary
      All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/10000 dilution

      Developed using the ECL technique.

      Performed under reducing conditions.

      Predicted band size: 50 kDa
      Observed band size: 45 kDa
      why is the actual band size different from the predicted?
      Additional bands at: 17 kDa (possible non-specific binding), 58 kDa (possible non-specific binding), 90 kDa (possible non-specific binding)


      Exposure time: 4 minutes


      The band observed at 45 kDa could potentially be a cleaved form of SUCLA2 due to the presence of 52 amino acid Transit peptide.

      This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 5% Bovine Serum Albumin before being incubated with ab133956 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Alternative products to Anti-SUCLA2 antibody (ab133956)

    •  
    • Product image

      Anti-SUCLA2 antibody [EPR14925] (ab183513)

      Applications: Flow Cyt, ICC/IF, IHC-P, IP, WB

    •  
    • Product image

      Anti-SUCLA2 antibody [EPR14924] (ab202582)

      Applications: Flow Cyt, ICC/IF, IHC-P, WB

    •  
    • Product image

      Anti-SUCLA2 antibody (ab97868)

      Applications: WB

    •  
    • Product image

      Anti-SUCLA2 antibody (ab240602)

      Applications: IP, WB

    •  
    • Product image

      Anti-SUCLA2 antibody (ab190845)

      Applications: WB

    Clear all

    Recently viewed products

    •  
    • Product image

      Anti-TNF alpha antibody [EPR22598-212] (ab255275)

    •  
    • Product image

      Anti-Ferritin Light Chain antibody [EPR5260] (ab109373)

    •  
    • Product image

      Anti-eIF4E antibody [Y448] (ab33766)

    •  
    • Product image

      Anti-MYL9 antibody [EPR13013(2)(B)] (ab187152)

    •  
    • Product image

      Anti-p73 antibody [EPR19560] - ChIP Grade (ab202474)

    •  
    • Product image

      Anti-Wnt3a antibody [EPR21889] (ab219412)

    Get resources and offers direct to your inbox Sign up
    © 2021 Astana Biomed Group LLP. All rights reserved.